Iman Jokar

****w ***th st Leawood,KS *****

Email: adu906@r.postjobfree.com

Contact: 913-***-****

Objective: Seeking a challenging position in medical sales with my broad range of academic and industry experience in an integrative environment.

Career Profile:

•Physician with over 10 years of experience of Clinical practice, in vivo and invitro research. I currently work as a medical device sales consultant in a company specialized in bariatric and geriatric equipments

•My therapeutic areas of experience include oncology, particularly Breast and urological malignancies.

Professional Experience:

Medical sales consultant at Ergo Midwest, Inc April2015-Current(7years)

•Manage specialty medical equipments and wound care systems used in healthcare system, hospitals and skilled nursing facilities.(7years)

The University of Kansas Cancer Center April 2012-April2015

Research Fellow (Oncology/Preclinical Therapeutic Drug Discovery) .

•Conduct in vivo proof of concept (POC) models in direct support of cancer related therapeutic discovery and translational research programs for the Cancer Center and external clients.

•Execute multiple simultaneous projects that require creating study protocols, experimental design, updating SOPs, planning timelines and personnel allocation.

•Develop novel xenograft and humanized primary and metastatic tumor models.

•Hands on experience with orthotopic models of prostate, breast, bladder, colon and lung cancer.

•Assessment of in vivo efficacy and toxicity for novel drug candidates, drug repurposing studies or novel combination therapies.

•Compile data, perform statistical analysis and generate reports as per requirements of various client researchers and departments.

•Manage operations of live animal imaging (bioluminescence and fluorescence). Develop and update SOPs for the operation of IVIS spectrum imaging system and provide hands on training.

Kansas University Medical Center Kansas City, KS

Department of pathology and laboratory Medicine

Research Fellow (Oncology/Breast cancer) 08/2008-03/2012

•Conducting invivo and exvivo studies in regulation of breast tumor

• Proliferation and survival in the presence of different chemokines such as ccl2 and cxcl1 in proliferation of epithelial tumors

Research Medical Center Kansas City, MO

Family Medicine Intern (Department of Family Medicine) 07/2007-07/2008

•Patient care, treatment, admissions, small surgeries and follow up

•Evaluation and Treatment of patients with CHF Exacerbations

•Evaluation and treatment of patients with Acute Myocardial infarction, unstable angina and cardiovascular ischemia

•Evaluation and Treatment of Patients with Acute or chronic arrhythmia

Kansas University Medical Center, Kansas City, Kansas

Heart Rhythm Management (Department of cardiology) 10/2004-06/2007

•Management of performing EKG

•Hearth Rhythm Monitoring In CCU and Telemetry Units

•Interpretation of EKG and diagnostic explanations

•Evaluation of Therapeutic Effects on Hearth Rhythm

•Acute and Chronic Arrhythmia evaluation

Kansas University Medical Center, Kansas city, KS

Research fellow (Department of surgery) 10/2005-06/2007

•Clinical Hypovolumic shock research

•Effect of hypovolumic shock in leukocyte adherence and inflammation process

Mashhad University of Medicine and health science

Manager and Physician (Shirvan health Center Shirvan,Khorasan,Iran)

01/2003-01/2004

•Management of the clinic on daily bases, Conducted patient visits and treated them, performed minor surgeries, Managed pharmacy, Managed mother and baby clinic with providing educational courses and vaccination.

Mashhad University of Medicine and health science

Manager and physician (Qaen Health Center, Qaen, Khorasan,Iran ) 10/2001-01/2003

•Management of the clinic, Visiting and treating Patients, Minor surgeries, Management of the pharmacy, Management of the mother and baby clinic with providing educational courses and vaccination.

Academics:

Internship Training:

•Research Medical Center Kansas City, MO

•Family Medicine Internship 07/2007-07/2008

Medical school training:

•Azad University-Mashhad, Iran

•7years combined BS/MD .09/1994 - 09/2001

Clinical studies:

•Establish the tumor incidence, progression and development of metastasis from intratibial model using the LnCaPLn3Luc cell line.

•Establish the tumor incidence, progression and development of metastasis of orthotopic prostate and tail vein cancer models using the LAPC4-Luc cell line.

•Establish the tumor incidence, progression and development of metastasis of orthotopic prostate and tail vein cancer models using the PC3-mm2-Luc cell line.

•Establish the tumor incidence, progression and development of metastasis of tail vein lung cancer models using the A549-luc2 cell line.

•Establish the tumor incidence, progression and development of metastasis of tail vein bladder cancer models using the KU-7-luc2 cell line.

•Establish the tumor incidence, progression and development of metastasis of Tail Vein prostate cancer models using the PC3MM2 luc2 cell line.

•Study to determine the efficacy of 2ME2 in a prostate cancer model when administered by an intra-peritoneal route.

•Pilot study with animals to test whether or not we can successfully image Cherenkov radiation (CR) emitted from lung tumor burden mice that receive and i.v. injection of 18FDG.

• determine the efficacy of pyrimethamine in the 143B osteosarcoma tumor model upon oral administration.

•Study to evaluate the effects of vitamin D deficiency on osteosarcoma pathobiology using bioluminescent osteosarcoma orthotopic mouse (BOOM) model [1]

•Mutations in the tumor suppressor Adenomatous Polyposis Coli (APC) are thought to initiate over 80% of all colon cancers.

•To study the acute dissemination of UCB Cd34 positive cells in NSG mice.

Publications:

Peer Reviewed Journal Articles/Abstracts

Iman Jokar. . Different patient exposures in internal medicine .

Final project in Medical school. Publication Status: Accepted.

Local Journal of Medicine 2001.

Namin F,Patel J,Jokar I,Lin Z,Dusing R,McCallum RW. Clinical Hallmarks of cyclic vomiting syndrome. American Journal of Gastroenterology .

Publication Status: Accepted.(Abstract)

American Journal of gastroenterology 2006.

130 ( Suppl. 2 ): A601

Iman Jokar,Nikki Cheng ccl2 derived from TGF-b signaling deficient fibroblasts regulates mammary carcinoma cell motility and cell growth through p42/44 MAPK and smad 3 signaling pathways(published).

Neoplasia. 2010 May; 12(5): 425–433.

Wei Bin Fang • Iman Jokar • Anna Chytil •Harold L. Moses • Ty Abel • Nikki Cheng

Loss of one Tgfbr2 allele in fibroblasts promotes

metastasis in MMTV: polyoma middle T transgenic and transplant mouse

Models of mammary tumor progression(published).

Clinical and Experimental Metastasis 03/2011; 28(4):351-66. · 3.52

Wei Bin Fang, Iman Jokar, An HYPERLINK "http://www.researchgate.net/researcher/84693105_An_Zou/" HYPERLINK "http://www.researchgate.net/researcher/84693105_An_Zou/" HYPERLINK "http://www.researchgate.net/researcher/84693105_An_Zou/" HYPERLINK "http://www.researchgate.net/researcher/84693105_An_Zou/" HYPERLINK "http://www.researchgate.net/researcher/84693105_An_Zou/" HYPERLINK "http://www.researchgate.net/researcher/84693105_An_Zou/" HYPERLINK "http://www.researchgate.net/researcher/84693105_An_Zou/" Zou, Diana Lambert, Prasanthi Dendukuri, Nikki Cheng

CCL2/CCR2 Chemokine Signaling Coordinates Survival and Motility of Breast Cancer Cells through Smad3 Protein- and p42/44 Mitogen-activated Protein Kinase (MAPK)-dependent Mechanisms.(Published)

Journal of Biological Chemistry 08/2012; 287(43):36593-608. · 4.77

Genetics: Early Online, published on June 9, 2014 as 10.1534/genetics.114.166587

Human Cancer Xenografts in Outbred Nude Mice can be confounded by Polymorphisms in a Modifier of Tumorogenesis

Maged Zeineldin Derek Jensen*, Smita R. Paranjape*, Nikhil K. Parelkar, Iman Jokar, George A. Vielhauer, and Kristi L. Neufeld*

Work Status

U.S Citizen

Language Fluency

English

Farsi

Contact this candidate